List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 165 studies with search of: Epstein-Barr Virus
Hide studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Completed Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
Condition: Epstein-Barr Virus Infections
Intervention:
2 Completed Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
Conditions: Epstein Barr Virus Infection;   Healthy
Intervention:
3 Recruiting Efficacy of Recombinant Epstein-Barr Virus (EBV) Vaccine in Patients With Nasopharyngeal Cancer Who Had Residual EBV DNA Load After Conventional Therapy
Conditions: Nasopharyngeal Cancer;   Epstein-Barr Virus Infections
Intervention: Biological: MVA-EBNA1/LMP2 Inj. vaccine
4 Recruiting Genetic Studies of Chronic Active Epstein-Barr Disease
Condition: Epstein-Barr Virus Infections
Intervention:
5 Recruiting Therapeutic Effects Of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies
Conditions: Non-Hodgkin's Lymphoma;   Epstein-Barr Virus
Intervention: Biological: EBV-specific T-cells
6 Recruiting Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
Condition: Epstein-Barr Virus Infections
Intervention: Biological: EBV specific T cells
7 Completed Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
Condition: Epstein-Barr Virus Infections
Intervention: Biological: Intravenous injection of EBV specific CTLS
8 Completed Prevention and Treatment of Epstein-Barr Virus (EBV) Lymphoma Following a Solid Organ Transplant Using EBV Specific Cytotoxic T Lymphocytes (CTLs).
Conditions: Epstein-Barr Virus Infections;   Lymphoproliferative Disorders
Intervention: Biological: Intravenous injection of EBV specific CTLs
9 Recruiting The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Conditions: Cytomegalovirus;   Epstein-Barr Virus Infections;   Herpesvirus Infection
Intervention:
10 Completed Modified Vaccinia Ankara (MVA) Vaccine Study
Conditions: Nasopharyngeal Neoplasms;   Epstein-Barr Virus Infections
Intervention: Drug: MVA Vaccine
11 Completed Surveillance Study of Viral Infections Following Lung Transplantation
Conditions: Lung Transplantation;   Bronchiolitis Obliterans;   Epstein-Barr Virus Infections;   Paramyxoviridae Infections
Intervention:
12 Recruiting Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)
Conditions: Burkitt Lymphoma;   Malaria;   Epstein-Barr Virus
Intervention:
13 Completed Activity of Valomaciclovir in Infectious Mononucleosis Due to Primary Epstein-Barr Virus Infection
Condition: Infectious Mononucleosis
Interventions: Drug: Valomaciclovir;   Drug: placebo
14 Completed Evaluation of Safety, Immune-Response and Efficacy of GSK Biologicals’ EBV (Epstein Barr Virus) Vaccine (268664).
Condition: Epstein Barr Virus (EBV) Infection
Intervention: Biological: EBV vaccine (268664)
15 Not yet recruiting Administration of Donor T Cells With the Caspase-9 Suicide Gene
Conditions: Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome;   Acute Myeloid Leukemia;   Chronic Myelogenous Leukemia;   Non Hodgkin Lymphoma;   Hemophagocytic Lymphohistiocytosis;   Familial Hemophagocytic Lymphohistiocytosis;   Hemophagocytic Syndrome;   Epstein Barr Virus Infection;   X-linked Lymphoproliferative Disease
Intervention: Drug: AP1903
16 Unknown † EBV Infection as a Risk Factor for PTLD in Pediatric and Adult Renal Transplant Recipients
Condition: Epstein-Barr Virus Infections
Intervention:
17 Recruiting Bortezomib Plus Rituximab for Initial Therapy of EBV+ PTLD
Conditions: Post-transplant Lymphoproliferative Disease;   Solid Organ Transplant;   Stem Cell Transplant (Bone Marrow Transplant);   Epstein Barr Virus Infections
Interventions: Drug: bortezomib;   Drug: rituximab
18 Completed Epstein-Barr Virus as a Possible Cause for Chronic Fatigue Syndrome
Condition: Chronic Fatigue Syndrome
Intervention:
19 Recruiting Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas
Condition: Lymphoma
Intervention: Biological: Autologous AdE1- Latent Membrane Protein CTLs
20 Recruiting A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Carcinoma
Intervention: Biological: Epstein-Barr Virus Specific Immunotherapy

Previous Page Studies Shown (1-20) Next Page (21-40)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services